Atlas FDA

HUMAN ALPHA-1 ANTITRYPSIN KIT SPAPLUS

FDA 510(k) clearance K123256 · decided 2013-07-03

Clearance details

K-number
K123256
Device name
HUMAN ALPHA-1 ANTITRYPSIN KIT SPAPLUS
Applicant
The Binding Site Group , Ltd.
Decision
Substantially Equivalent
Date received
2012-10-18
Decision date
2013-07-03
Days to decision
258 days
Clearance type
Traditional
Product code
DEM
Device class
2
Regulation number
866.5130
Medical specialty
Immunology
Advisory committee
Immunology
Location
Birmingham, GB
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch The Binding Site Group

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
DIMENSION VISTA A1AT FLEX REAGENT CARTRIDGE AND PROTEIN 1 CALIBRATOR AND CONTROL MEDIUM AND HIGH (K063610)Dade Behring, Inc.2007-01-11
N ANTISERA TO HUMAN ALPHA1-ANTITRYPSIN (K053072)Dade Behring, Inc.2006-03-28
VITROS CHEMISTRY PRODUCTS AAT REAGENT, CALIBRATOR KIT 99 AND AAT PERFORMANCE VERIFIERS I, II AND III (K052819)Ortho-Clinical Diagnostics, Inc.2005-12-23
QUANTIA A1-AT (K050596)Biokit, S.A.2005-05-13
ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAY (K031857)Bayer Diagnostics Corp.2003-09-04
MININEPH A-1 ANTITRYPSIN ANTISERUM, HIGH AND LOW SERUM CONTROLS (K011663)The Binding Site, Ltd.2001-07-30
TINA-QUANT ALPHA-1 ANTITRYPSIN (K010978)Rochdiag2001-05-18
K-ASSAY ALPHA-1 AT (K993444)Kamiya Biomedical Co.1999-11-24
TINA-QUANT ALPHA PARTICLE-1-ANTITRYPSIN ASSAY (K972640)Boehringer Mannheim Corp.1998-01-09
CHEMMATE UCHL1 (CD45RO) PREDILUTED ANTIBODY FOR IMMUNOHISTOCHEMICAL STAINING (K973389)Ventana Medical Systems, Inc.1997-10-03
CHEMMATE LAMBDA (K973392)Ventana Medical Systems, Inc.1997-10-03
CHEMMATE KAPPA (K973391)Ventana Medical Systems, Inc.1997-10-03

Recalls involving this device

No recalls on record reference this clearance.